+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 496775-62-3
496775-62-3,MFCD22380664
Catalog No.:AA00DB32

496775-62-3 | Eltrombopag olamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%
in stock  
$11.00   $8.00
- +
10mg
98%
in stock  
$14.00   $10.00
- +
100mg
98%
in stock  
$39.00   $28.00
- +
250mg
98%
in stock  
$58.00   $41.00
- +
1g
98%
in stock  
$164.00   $115.00
- +
5g
97%
in stock  
$660.00   $462.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00DB32
Chemical Name:
Eltrombopag olamine
CAS Number:
496775-62-3
Molecular Formula:
C29H36N6O6
Molecular Weight:
564.6327
MDL Number:
MFCD22380664
SMILES:
OC(=O)c1cccc(c1)C1=CC=CC(=NNc2c(C)[nH]n(c2=O)c2ccc(c(c2)C)C)C1=O.OCCN.OCCN
Properties
Computed Properties
 
Complexity:
822  
Covalently-Bonded Unit Count:
3  
Heavy Atom Count:
41  
Hydrogen Bond Acceptor Count:
11  
Hydrogen Bond Donor Count:
7  
Rotatable Bond Count:
7  

Downstream Synthesis Route

[1]CurrentPatentAssignee:CHANGZHOUPHARMACEUTICALFACTORYCO.,LTD.-CN106966984,2017,ALocationinpatent:Paragraph0011;0012;0013;0014;0015;0016;0017;0018

[2]CurrentPatentAssignee:WUHANWUYAOSCIENCETECH-CN111718297,2020,ALocationinpatent:Paragraph0040-0085

[3]CurrentPatentAssignee:EASTPHARMALIMITED-WO2022/71896,2022,A1Locationinpatent:Page/Pagecolumn12-13

[4]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn2

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn3

[6]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN108191763,2018,ALocationinpatent:Paragraph0056;0078;0079;0080

[7]CurrentPatentAssignee:ZHEJIANGA&FUNIVERSITY-CN112979481,2021,ALocationinpatent:Paragraph0054;0059-0060

[8]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/256212,2010,A1Locationinpatent:Page/Pagecolumn14

[9]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn2-3

[10]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2015/87845,2015,A1Locationinpatent:Paragraph0226;0227;0228

[11]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2016/35018,2016,A1Locationinpatent:Page/Pagecolumn14-15

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn3

376592-93-7    925633-57-4    141-43-5   
eltrombopagolamine 

[1]Patent:US2010/256212,2010,A1.Locationinpatent:Page/Pagecolumn14

[1]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/256212,2010,A1Locationinpatent:Page/Pagecolumn15

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 496775-62-3
1033040-23-1

1033040-23-1
Building Blocks
More >
Tags:496775-62-3 Molecular Formula|496775-62-3 MDL|496775-62-3 SMILES|496775-62-3 Eltrombopag olamine